Simultaneous determination of isoniazid, pyrazinamide, rifampicin and acetylisoniazid in human plasma by high-performance liquid chromatography

Analytical Sciences

Volumn 26, Issue 11, 2010, Pages 1133-1138

  Zhou, Zhifeng ^a   Chen, Lingyun ^a   Liu, Peng ^a   Shen, Mei ^a   Zou, Fei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; HYDRAZINE; PATIENT MONITORING; PATIENT TREATMENT; PLASMA (HUMAN); SIGNAL TO NOISE RATIO;

CALIBRATION CURVES; GRADIENT ELUTION; HUMAN PLASMAS; LIMIT OF DETECTION; SIGNAL TO NOISE; SIMULTANEOUS DETERMINATIONS; THERAPEUTIC DRUG MONITORING; TUBERCULOSIS PATIENTS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 78249258384     PISSN: 09106340     EISSN: 13482246     Source Type: Journal    
DOI: 10.2116/analsci.26.1133     Document Type: Article

References (25)

1. World Health Organization, 10 Facts about Tuberculosis (March 2009), http://www.who.int/features/factfiles/tuberculosis/en/.
2. World Health Organization, "Treatment of Tuberculosis: Guideline for National Programmes", 3rd ed., 2003, Geneva.
3. J. B. Mehta, H. Shantaveerapa, R. P. Byrd Jr, S. E. Morton, F. Fountain, and T. M. Roy, Chest, 2001, 120, 1520.
4. J. Tappero, W. Bradford, T. Agerton, P. Hopewell, A. Reingold, S. Lockman, A. Oyewo, E. Talbot, T. Kenyon, T. Moeti, H. Moffat, and C. Peloquin, Clin. Infect. Dis., 2005, 41, 461.
5. T. Deguchi, M. Mashimo, and T. Suzuki, J. Biol. Chem., 1990, 265, 12757.
6. H. I. Seifart, D. P. Parkin, F. J. H. Botha, P. R. Donald, and B. J. V. D. Walt, Pharmacoepidemiol. Drug Saf., 2001, 10, 127.
7. M. E. Kimerling, P. Phillips, P. Patterson, M. Hall, C. A. Robinson, and N. E. Dunlap, Chest, 1998, 113, 1178.
8. E. Calleri, E. De Lorenzi, S. Furlanetto, G. Massolini, and G. Caccialanza, J. Pharm. Biomed. Anal., 2002, 29, 1089.
9. D. T. T. Nguyen, D. Guillarme, S. Rudaz, and J. L. Veuthey, J. Sep. Sci., 2008, 31, 1050.
10. A. Espinosa-Mansilla, M. I. Acedo-Valenzuela, A. M. de la Pena, F. C. Canada, and F. S. Lopez, Talanta, 2002, 58, 273.
11. B. D. Glass, S. Agatonovic-Kustrin, Y. J. Chen, and M. H. Wisch, J. Chromatogr. Sci., 2007, 45, 38.
12. M. Y. Khuhawar and F. M. A. Rind, J. Chromatogr., B, 2002, 766, 357.
13. B. Mohan, N. Sharda, and S. Singh, J. Pharm. Biomed. Anal., 2003, 31, 607.
14. A. Walubo, P. Smith, and P. I. Folb, J. Chromatogr., B, 1994, 658, 391.
15. A. L. Allanson, M. M. Cotton, J. N. A. Tettey, and A. C. Boyter, J. Pharm. Biomed. Anal., 2007, 44, 963.
16. L. A. Moussa, C. E. Khassouani, R. Soulaymania, M. Jana, G. Cassanas, R. Alric, and B. Hüe, J. Chromatogr., B, 2001, 766, 181.
17. R. C. Hartkoorn, S. Khoo, D. J. Back, J. F. Tjia, C. J. Waitt, M. Chaponda, G. Davies, A. Ardrey, S. Ashleigh, and S. A. Ward, J. Chromatogr., B, 2007, 857, 76.
18. S. Unsalan, M. Sancar, B. Bekce, P. M. Clark, T. Karagoz, F. V. Izzettin, and S. Rollas, Chromatographia, 2005, 61, 595.
19. Z. Gong, Y. Basir, D. Chu, and M. McCort-Tipton, J. Chromatogr., B, 2009, 877, 1698.
20. L. Huang, F. Marzan, A. L. Jayewardene, P. S. Lizak, X. Li, and F. T. Aweeka, J. Chromatogr., B, 2009, 877, 285.
21. X. Y. Chen, B. Song, H. J. Jiang, K. Yu, and D. F. Zhong, Rapid Commun. Mass Spectrom., 2005, 19, 2591.
22. S. H. Song, S. H. Jun, K. U. Park, Y. Yoon, J. H. Lee, J. Q. Kim, and J. Song, Rapid Commun. Mass Spectrom., 2007, 21, 1331.
23. K. Y. Ng, H. Y. Zhou, Y. L. Zhang, B. Hybertson, T. Randolph, and U. Christians, J. Chromatogr., B, 2007, 847, 188.
24. H. Fox and J. Gibas, J. Org. Chem., 1953, 18, 1375.
25. U. S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, May 2001, http://www.fda.gov/CDER/GUIDANCE/4252fnl.pdf.